首页> 外国专利> PHARMACEUTICAL COMPOSITION OF ARTEMISIA EXTRACT USING GASTRO-RETENTIVE DRUG DELIVERY SYSTEM AND ITS ORAL SUSTAINED RELEASE FORMULATION

PHARMACEUTICAL COMPOSITION OF ARTEMISIA EXTRACT USING GASTRO-RETENTIVE DRUG DELIVERY SYSTEM AND ITS ORAL SUSTAINED RELEASE FORMULATION

机译:胃保留药物输送系统的蒿提取物的药物组成及其口服缓释制剂

摘要

A pharmaceutical composition with an artemisia extract is provided to maintain a floating state of a slow-release oral medicine by a digestive fluid or body fluid in order to improve an absorption rate for gastrointestinal tracts. A pharmaceutical composition with an artemisia extract uses a drug delivery system including a swelling polymer, foam generator, slow-release adjustment polymer, and a dissolution assisting agent. The swelling polymer is selected from the group consisting of hydroxy propyl methyl cellulose, hydroxypropyl cellulose, sodium carboxymethylcellulose, calcium carboxymethyl cellulose, propylene glycol alginate, polyvinyl alcohol, povidone, carbomer, cellulose acetate phthalate, hydroxypropyl-methylcellulose phthalate, hydroxypropylmethylcellulose tri mellidate, and hydroxy propyl methyl cellulose maleate.
机译:提供具有蒿提取物的药物组合物,以通过消化液或体液维持缓释口服药物的漂浮状态,从而提高胃肠道的吸收率。具有蒿提取物的药物组合物使用包括溶胀聚合物,泡沫发生剂,缓释调节聚合物和溶解辅助剂的药物递送系统。溶胀聚合物选自羟丙基甲基纤维素,羟丙基纤维素,羧甲基纤维素钠,羧甲基纤维素钙,褐藻酸丙二醇酯,聚乙烯醇,聚维酮,卡波姆,邻苯二甲酸乙酸纤维素,羟丙基-甲基纤维素邻苯二甲酸酯,羟丙基甲基纤维素三苯甲酸酯和羟丙基甲基纤维素马来酸酯。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号